The Alzheimer's Association is proud to celebrate the individuals who have made significant contributions to further the vision of a world without Alzheimer's disease.
AAIC provides the Alzheimer's Association with the opportunity to present awards to some of the most prominent leaders in the field. These prestigious awards recognize the work of distinguished Alzheimer's researchers, as well as those who are just beginning their career in this vital field. View the AAIC 2016 award winners.
The AAIC Lifetime Achievement Awards recognize a senior investigator whose contributions, whether they have been in research, leadership or mentorship, have shown a lasting impact on the field and whose body of work has demonstrated a lifetime commitment towards progress against Alzheimer's and dementia.
The awards are named in honor of Henry Wisniewski, M.D., Ph.D.; Khalid Iqbal, Ph.D.; and Bengt Winblad, M.D., Ph.D.—co-founders of the Alzheimer's Association scientific conference, now known as the Alzheimer's Association International Conference (AAIC). Since its inception and first iteration they each held key leadership roles in planning and conceptualizing the conference:
The awards will be presented at AAIC 2017. Nominations are accepted through February 15, 2017.
The Jerome H. Stone Philanthropy Award for Alzheimer's Research honors the legacy of Mr. Jerome Stone, a visionary who was among the first to call for investment in Alzheimer's research. Inspired by the loving memory of his late wife, Evelyn T. Stone, he took the helm of the Alzheimer's movement as the primary founder of the Alzheimer's Association.
Mr. Stone was renowned for his leadership, determination and generosity in the fight against Alzheimer’s, and for his support of research in particular. For many years, he served as the honorary chair of the Alzheimer's Association National Board of Directors. Mr. Stone passed away on January 1, 2015 at the age of 101.
This award, given in his name, honors the world's top philanthropists for advancing scientific progress toward treatment and prevention of Alzheimer's disease through their generous commitment to research.
The Inge Grundke-Iqbal Award for Alzheimer's Research is presented to the senior author of the most impactful study published in Alzheimer's research over the preceding two years.
Only members from the International Society to Advance Alzheimer’s Research and Treatment (ISTAART) may nominate candidates. Please consider potential candidates to nominate for this exciting award.
Nomination Period: Submit a nomination(s) now through February 17.
To submit your nomination(s), enter the following details on the online form:
2014: Kári Stefánsson, M.D., Dr. Med.
“A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline”
2015: Li Gan, Ph.D.
“Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models”
2016: Tsuneya Ikezu, M.D., Ph.D.
“Depletion of microglia and inhibition of exosome synthesis halt tau propagation”
About Dr. Inge Grundke-Iqbal
Inge Grundke-Iqbal served as Professor and Head of Neuroimmunology at the New York State Institute for Basic Research in Developmental Disabilities from 1977 until her passing in September 2012. She was a world renowned neuroscientist and Alzheimer disease researcher. She was author/co-author of over 250 scientific publications in prestigious American and international journals and books. Dr. Grundke-Iqbal made several seminal discoveries in the biology of Alzheimer's disease and related conditions. Her discovery of the abnormal hyperphosphorylation of tau opened a whole new area of research in neurodegeneration, especially Alzheimer's disease and related tauopathies. Her research contributions won her several U.S. Public Health Service, National Institutes of Health and non-federal research grants and honors. Dr. Grundke-Iqbal served as a member of the International Scientific Advisory Committee of the International Conference on Alzheimer's Disease and Related Disorders (now known as the Alzheimer's Association International Conference).
The de Leon Prizes in Neuroimaging recognize a senior scientist and a new investigator (first authors) who are judged to have each published the best paper in any peer-reviewed journal related to the topic of in-vivo neuroimaging of a neurodegenerative process. Members of the ISTAART Neuroimaging Professional Interest Area (NPIA) are the nominating body for the two awards.
Submissions for AAIC 2017 will be collected in January 2017.
Using review scores as a guide, the AIC Chairs judge and select the best oral and poster presentations presented during AIC. The 2017 recipients will be announced onsite during AIC 2017.
Competitions are held in each conference program theme to determine the best posters by students and post-docs at AAIC. Judging will take place onsite by the Scientific Program Committee and invited guest judges. The competition is based on the four programmatic themes of AAIC: Basic and Translational Science, Diagnosis and Prognosis, Public Health and Psychosocial, and Therapeutics. Students and post-docs may submit their interest in the poster competition during abstract submission.
The Scientific Program Committee is now accepting submissions for poster presentations, oral presentations and featured research sessions. Submission deadline is January 30. Need more time? Become an ISTAART member and extend your deadline until February 2.
ISTAART Members receive an extended abstract submission deadline of February 2! Join today and receive this exclusive member benefit and more.
July 16 – 20: Annual Conference
July 14 – 15: Preconferences
July 16 – 19: Exhibit Dates
Cobblestone streets, fish and chips and entertainment old and new await you!
Registration opens in February.